Cash flow CyberAgent, Inc.

Stocks

4751

JP3311400000

Advertising & Marketing

Delayed Japan Exchange Other stock markets 05:26:55 22/07/2026 BST			5-day change	1st Jan Change
1,397.00 ^JPY	-3.56%		-5.32%	+4.33%

06-18	OpenAI to Start Displaying Ads on ChatGPT for Japanese Users	MT
06-15	Sinking Oil Prices Spur Asian Stock Markets Higher	MT

529c0d05.B1Ow4f86mbbgGZ_mozt54EsDZM2r3RWno4OElVr63XM.ayn3uItprN_Rfvbf02tUlSVoXL3f8ELB0uri4Wiek0RYNcWXtHnT96Y0rw

Published financial data: CYBERAGENT, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: September	2021	2022	2023	2024	2025
Revenues	666B	710B	719B	801B	874B
Total Revenues	666B	710B	719B	801B	874B
Cost of Goods Sold, Total	434B	491B	528B	582B	610B
Gross Profit	232B	219B	192B	219B	264B
Selling General & Admin Expenses, Total	128B	151B	169B	179B	192B
Provision for Bad Debts	84M	-	-	599M	199M
Depreciation & Amortization - (IS)	-	-	170M	-	-
Other Operating Expenses, Total	128B	151B	169B	179B	193B
Operating Income	104B	67.55B	22.18B	39.48B	71.5B
Interest Expense, Total	-17M	-54M	-127M	-245M	-428M
Interest And Investment Income	476M	523M	563M	750M	881M
Net Interest Expenses	459M	469M	436M	505M	453M
Income (Loss) On Equity Invest.	-314M	-313M	-91M	-251M	-244M
Currency Exchange Gains (Loss)	150M	-	-191M	-474M	-
Other Non Operating Income (Expenses)	100M	278M	488M	449M	246M
EBT, Excl. Unusual Items	104B	67.99B	22.82B	39.71B	71.96B
Gain (Loss) On Sale Of Investments	1.58B	1.21B	885M	71M	172M
Gain (Loss) On Sale Of Assets	-	330M	-	-	1.76B
Asset Writedown	-5.1B	-7.74B	-1.45B	-5.6B	-6.32B
Other Unusual Items	-448M	-550M	-1.93B	-2.97B	-1.34B
EBT, Incl. Unusual Items	100B	61.24B	20.33B	31.21B	66.23B
Income Tax Expense	34.05B	23.14B	11.18B	10.84B	24.26B
Earnings From Continuing Operations	66.36B	38.1B	9.15B	20.38B	41.96B
Net Income to Company	66.36B	38.1B	9.15B	20.38B	41.96B
Minority Interest	-25.12B	-15.19B	-5.61B	-4.4B	-10.3B
Net Income - (IS)	41.24B	22.9B	3.54B	15.98B	31.67B
Net Income to Common Incl Extra Items	41.24B	22.9B	3.54B	15.98B	31.67B
Net Income to Common Excl. Extra Items	41.24B	22.9B	3.54B	15.98B	31.67B
Per Share Items
Net EPS - Basic	81.68	45.29	7	31.56	62.52
Basic EPS - Continuing Operations	81.68	45.29	7	31.56	62.52
Basic Weighted Average Shares Outstanding	505M	506M	506M	506M	506M
Net EPS - Diluted	77.9	45.29	7	29.49	58.96
Diluted EPS - Continuing Operations	77.9	45.29	7	29.49	58.96
Diluted Weighted Average Shares Outstanding	532M	533M	544M	548M	536M
Normalized Basic EPS	79.46	53.99	17.1	40.34	68.47
Normalized Diluted EPS	75.35	51.25	15.92	37.28	64.73
Dividend Per Share	11	14	15	16	17
Payout Ratio	10.4	24.26	199.86	47.45	25.56
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	114B	76.24B	30.29B	49.92B	80.62B
EBITA	104B	67.55B	22.18B	39.48B	71.5B
EBIT	104B	67.55B	22.18B	39.48B	71.5B
Effective Tax Rate - (Ratio)	33.91	37.79	54.98	34.72	36.64
Normalized Net Income	40.12B	27.3B	8.65B	20.42B	34.68B
Supplemental Operating Expense Items
Advertising Expense	41.29B	57.3B	60.98B	65.4B	68.19B
Selling and Marketing Expenses	41.29B	57.3B	60.98B	65.4B	68.19B
Research And Development Expense From Footnotes	6.02B	7.24B	9.85B	5.67B	3.85B

Fiscal Period: September	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	181B	166B	200B	210B	230B
Total Cash And Short Term Investments	181B	166B	200B	210B	230B
Accounts Receivable, Total	93.75B	87.56B	99.74B	99B	105B
Total Receivables	93.75B	87.56B	99.74B	99B	105B
Inventory	3.23B	4.26B	8.98B	11.59B	10.3B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	22.87B	34.11B	39.68B	38B	45.3B
Total Current Assets	301B	292B	348B	359B	390B
Net Property Plant And Equipment	16.74B	18.97B	24.59B	27.28B	32.6B
Long-term Investments	28.76B	41.79B	60.73B	71.23B	66.45B
Goodwill	4.96B	4.84B	7.08B	14.78B	13.89B
Other Intangibles, Total	21.48B	17.21B	26.47B	34.52B	42.87B
Loans Receivable Long-Term	492M	226M	108M	863M	1.15B
Deferred Tax Assets Long-Term	8.45B	7.03B	8.2B	9.33B	9.95B
Deferred Charges Long-Term	42M	21M	64M	48M	38M
Other Long-Term Assets, Total	2M	3M	2M	3M	2M
Total Assets	382B	382B	475B	517B	557B
Liabilities
Accounts Payable, Total	56.06B	59.21B	71.6B	74.24B	81.75B
Short-term Borrowings	1.04B	2.38B	3.14B	600M	600M
Current Portion of Long-Term Debt	-	20.02B	-	20.02B	-
Current Income Taxes Payable	47.46B	20.89B	24.66B	33.21B	51.09B
Deferred Tax Liability Current	-	-	-	-	-
Other Current Liabilities	36.16B	27.41B	34.82B	40.16B	44.35B
Total Current Liabilities	141B	130B	134B	168B	178B
Long-Term Debt	41.4B	23.85B	104B	86.16B	92.77B
Deferred Tax Liability Non Current	1.29B	371M	1.04B	2.8B	2.45B
Other Non Current Liabilities	5.03B	6.55B	7.58B	8.99B	8.48B
Total Liabilities	188B	161B	247B	266B	281B
Common Stock, Total	7.2B	7.24B	7.37B	7.44B	7.65B
Additional Paid In Capital	11.2B	11.64B	12.22B	12.3B	12.37B
Retained Earnings	100B	118B	114B	123B	146B
Treasury Stock	-67M	-1M	-1M	-1M	-1M
Comprehensive Income and Other	11.07B	7.93B	9.48B	15.84B	17.47B
Total Common Equity	130B	144B	143B	158B	184B
Minority Interest	63.94B	76.9B	85.4B	92.23B	91.93B
Total Equity	194B	221B	228B	251B	276B
Total Liabilities And Equity	382B	382B	475B	517B	557B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	505M	506M	506M	506M	507M
ECS Total Common Shares Outstanding	505M	506M	506M	506M	507M
Book Value / Share	256.9	285.3	282.61	312.59	362.59
Tangible Book Value	103B	122B	109B	109B	127B
Tangible Book Value Per Share	204.58	241.71	216.31	215.23	250.58
Total Debt	42.44B	46.26B	107B	107B	93.37B
Net Debt	-139B	-120B	-92.5B	-103B	-136B
Minority Interest, Total (Incl. Fin. Div)	63.94B	76.9B	85.4B	92.23B	91.93B
Inventories - Work In Process, Total	600M	705M	2.83B	3.3B	3.46B
Inventories - Finished Goods, Total	2.59B	3.5B	5.77B	7.92B	6.12B
Inventories - Others	35M	56M	377M	375M	730M
Full Time Employees	5.94K	6.34K	7.25K	7.72K	8.15K
Accumulated Allowance for Doubtful Accounts (Supple)	130M	36M	489M	363M	93M

Fiscal Period: September	2021	2022	2023	2024	2025
Net Income	100B	61.24B	20.33B	31.21B	66.23B
Depreciation & Amortization - CF	10.11B	8.68B	8.1B	10.44B	9.12B
Amortization of Goodwill and Intangible Assets - (CF)	-	-	-	-	-
Depreciation & Amortization, Total	10.11B	8.68B	8.1B	10.44B	9.12B
(Gain) Loss From Sale Of Asset	5.1B	7.74B	1.45B	5.6B	4.56B
(Gain) Loss on Sale of Investments - (CF)	-1.44B	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Other Operating Activities, Total	-17.44B	-44.93B	-11.75B	-6.95B	-14.49B
Change In Accounts Receivable	-16.18B	2.16B	-12.13B	98M	-5.21B
Change In Inventories	-	-	-2.78B	-2.83B	2.23B
Change In Accounts Payable	27.24B	-9.81B	13.04B	10.68B	13.5B
Change in Other Net Operating Assets	1.81B	-7.14B	4.57B	4.99B	3.58B
Cash from Operations	110B	17.95B	20.82B	53.23B	79.52B
Capital Expenditure	-3.83B	-16.93B	-13.08B	-6.68B	-10.72B
Sale of Property, Plant, and Equipment	-	-	-	-	7.76B
Cash Acquisitions	-5.36B	-	-	-11.1B	-
Divestitures	1.78B	-1.64B	-	-	-
Sale (Purchase) of Intangible assets	-8.63B	-9.16B	-12.5B	-14.24B	-17.06B
Investment in Marketable and Equity Securities, Total	-11B	-1.96B	-11.83B	-1.34B	-10.52B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-1.5B	-1.72B	-2.89B	-4.98B	-283M
Cash from Investing	-28.54B	-31.41B	-40.29B	-38.33B	-30.82B
Short Term Debt Issued, Total	-	2.37B	-	-	-
Long-Term Debt Issued, Total	-	3.18B	81.46B	7.39B	9.89B
Total Debt Issued	-	5.55B	81.46B	7.39B	9.89B
Short Term Debt Repaid, Total	-	-	-	-2.54B	-
Long-Term Debt Repaid, Total	-	-	-20B	-1.65B	-25.78B
Total Debt Repaid	-	-	-20B	-4.2B	-25.78B
Issuance of Common Stock	-	-	-	-	1.05B
Common Dividends Paid	-4.29B	-5.56B	-7.08B	-7.58B	-8.09B
Common & Preferred Stock Dividends Paid	-4.29B	-5.56B	-7.08B	-7.58B	-8.09B
Other Financing Activities, Total	4.66B	-2.8B	-897M	-807M	-10.92B
Cash from Financing	374M	-2.8B	53.49B	-5.2B	-33.86B
Foreign Exchange Rate Adjustments	267M	292M	-278M	-434M	184M
Miscellaneous Cash Flow Adjustments	1M	-72M	-	83M	-1M
Net Change in Cash	81.71B	-16.05B	33.74B	9.35B	15.02B
Supplemental Items
Cash Interest Paid	17M	54M	127M	245M	426M
Cash Income Tax Paid (Refund)	17.8B	45.3B	12.04B	7.17B	14.83B
Levered Free Cash Flow	96.94B	-13.47B	-2.59B	30.39B	43.57B
Unlevered Free Cash Flow	96.95B	-13.43B	-2.51B	30.54B	43.83B
Change In Net Working Capital	-34.31B	38.25B	-1.09B	-16.34B	-17.81B
Net Debt Issued / Repaid	-	5.55B	61.46B	3.19B	-15.89B

Fiscal Period: September	2021	2022	2023	2024	2025
Profitability
Return on Assets	20.22	11.05	3.23	4.98	8.32
Return on Total Capital	32.07	16.76	4.6	7.12	12.31
Return On Equity %	41.29	18.36	4.07	8.51	15.95
Return on Common Equity	37.44	16.7	2.46	10.6	18.52
Margin Analysis
Gross Profit Margin %	34.78	30.78	26.64	27.3	30.21
SG&A Margin	19.16	21.26	23.53	22.3	22.01
EBITDA Margin %	17.13	10.74	4.21	6.23	9.22
EBITA Margin %	15.61	9.52	3.08	4.93	8.18
EBIT Margin %	15.61	9.52	3.08	4.93	8.18
Income From Continuing Operations Margin %	9.96	5.37	1.27	2.54	4.8
Net Income Margin %	6.19	3.23	0.49	1.99	3.62
Net Avail. For Common Margin %	6.19	3.23	0.49	1.99	3.62
Normalized Net Income Margin	6.02	3.85	1.2	2.55	3.97
Levered Free Cash Flow Margin	14.55	-1.9	-0.36	3.79	4.98
Unlevered Free Cash Flow Margin	14.55	-1.89	-0.35	3.81	5.02
Asset Turnover
Asset Turnover	2.07	1.86	1.68	1.62	1.63
Fixed Assets Turnover	44.44	39.76	33.03	30.9	29.2
Receivables Turnover (Average Receivables)	7.56	7.83	7.68	8.06	8.58
Inventory Turnover (Average Inventory)	163.83	131.25	79.73	56.63	55.71
Short Term Liquidity
Current Ratio	2.14	2.25	2.59	2.13	2.19
Quick Ratio	1.96	1.95	2.23	1.84	1.88
Operating Cash Flow to Current Liabilities	0.78	0.14	0.16	0.32	0.45
Days Sales Outstanding (Average Receivables)	48.29	46.61	47.51	45.39	42.54
Days Outstanding Inventory (Average Inventory)	2.23	2.78	4.58	6.46	6.55
Average Days Payable Outstanding	41.48	42.72	44.83	45.61	46.77
Cash Conversion Cycle (Average Days)	9.03	6.67	7.26	6.24	2.33
Long Term Solvency
Total Debt/Equity	21.9	20.91	46.87	42.62	33.87
Total Debt / Total Capital	17.97	17.29	31.91	29.89	25.3
LT Debt/Equity	21.36	10.78	45.5	34.4	33.65
Long-Term Debt / Total Capital	17.53	8.92	30.98	24.12	25.14
Total Liabilities / Total Assets	49.3	42.07	51.93	51.52	50.52
EBIT / Interest Expense	6.12K	1.25K	174.67	161.16	167.07
EBITDA / Interest Expense	6.71K	1.41K	238.48	203.76	188.36
(EBITDA - Capex) / Interest Expense	6.49K	1.1K	135.5	176.5	163.32
Total Debt / EBITDA	0.37	0.61	3.54	2.14	1.16
Net Debt / EBITDA	-1.22	-1.57	-3.05	-2.07	-1.69
Total Debt / (EBITDA - Capex)	0.38	0.78	6.22	2.47	1.34
Net Debt / (EBITDA - Capex)	-1.26	-2.02	-5.37	-2.39	-1.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	39.21	6.57	1.34	11.37	9.09
Gross Profit, 1 Yr. Growth %	64.77	-5.69	-12.29	14.15	20.7
EBITDA, 1 Yr. Growth %	168.09	-33.18	-60.27	64.83	61.49
EBITA, 1 Yr. Growth %	207.29	-35.04	-67.16	78	81.09
EBIT, 1 Yr. Growth %	207.29	-35.04	-67.16	78	81.09
Earnings From Cont. Operations, 1 Yr. Growth %	366.82	-42.59	-75.98	122.65	105.95
Net Income, 1 Yr. Growth %	528.02	-44.47	-84.54	351.33	98.2
Normalized Net Income, 1 Yr. Growth %	199.25	-31.96	-68.3	135.98	69.8
Diluted EPS Before Extra, 1 Yr. Growth %	534.14	-41.86	-84.55	321.53	99.97
Accounts Receivable, 1 Yr. Growth %	13.63	-6.6	13.92	-0.75	5.82
Inventory, 1 Yr. Growth %	55.25	32.11	110.63	29.15	-11.13
Net Property, Plant and Equip., 1 Yr. Growth %	26.43	13.35	29.58	10.95	19.49
Total Assets, 1 Yr. Growth %	46.6	-0.08	24.43	8.73	7.83
Tangible Book Value, 1 Yr. Growth %	56.79	18.26	-10.46	-0.47	16.52
Common Equity, 1 Yr. Growth %	43.54	11.16	-0.89	10.64	16.1
Cash From Operations, 1 Yr. Growth %	196.02	-83.63	16.03	155.65	49.38
Capital Expenditures, 1 Yr. Growth %	-6.37	341.47	-22.73	-48.93	60.46
Levered Free Cash Flow, 1 Yr. Growth %	519.94	-113.89	-80.74	-1.27K	43.37
Unlevered Free Cash Flow, 1 Yr. Growth %	519.66	-113.86	-81.29	-1.32K	43.52
Dividend Per Share, 1 Yr. Growth %	29.41	27.27	7.14	6.67	6.25
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.18	21.8	3.92	6.24	10.22
Gross Profit, 2 Yr. CAGR %	31.84	24.66	-9.05	0.06	17.38
EBITDA, 2 Yr. CAGR %	69.42	33.84	-48.48	-19.08	63.15
EBITA, 2 Yr. CAGR %	83.67	41.29	-53.81	-23.55	79.54
EBIT, 2 Yr. CAGR %	83.67	41.29	-53.81	-23.55	79.54
Earnings From Cont. Operations, 2 Yr. CAGR %	230.86	63.7	-62.86	-26.87	114.14
Net Income, 2 Yr. CAGR %	393.42	86.74	-70.7	-16.47	199.09
Normalized Net Income, 2 Yr. CAGR %	65.59	42.69	-53.56	-13.5	100.17
Diluted EPS Before Extra, 2 Yr. CAGR %	405.03	92.01	-70.03	-19.31	190.33
Accounts Receivable, 2 Yr. CAGR %	16.49	3.02	3.15	6.33	2.48
Inventory, 2 Yr. CAGR %	86.85	43.21	66.81	64.93	7.14
Net Property, Plant and Equip., 2 Yr. CAGR %	13.49	19.71	21.19	19.9	15.14
Total Assets, 2 Yr. CAGR %	30.37	21.03	11.5	16.31	8.28
Tangible Book Value, 2 Yr. CAGR %	36.25	36.17	2.9	-5.6	7.69
Common Equity, 2 Yr. CAGR %	27.33	26.32	4.96	4.72	13.34
Cash From Operations, 2 Yr. CAGR %	171.07	-30.38	-56.41	72.23	95.42
Capital Expenditures, 2 Yr. CAGR %	-21.09	103.31	84.69	-37.18	-9.48
Levered Free Cash Flow, 2 Yr. CAGR %	433.69	-7.2	-83.64	50.22	309.9
Unlevered Free Cash Flow, 2 Yr. CAGR %	433.18	-7.34	-83.9	50.79	317.6
Dividend Per Share, 2 Yr. CAGR %	15.47	28.34	16.77	6.9	6.46
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	16.67	16.1	14.56	6.35	7.18
Gross Profit, 3 Yr. CAGR %	21.24	17.91	10.87	-1.89	6.51
EBITDA, 3 Yr. CAGR %	43.1	24.24	-10.72	-24.08	1.88
EBITA, 3 Yr. CAGR %	51.06	29.89	-13.13	-27.59	1.91
EBIT, 3 Yr. CAGR %	51.06	29.89	-13.13	-27.59	1.91
Earnings From Cont. Operations, 3 Yr. CAGR %	87.2	84.54	-13.65	-32.54	3.28
Net Income, 3 Yr. CAGR %	104.12	138.22	-18.61	-27.1	11.41
Normalized Net Income, 3 Yr. CAGR %	47.35	23.1	-13.58	-20.15	8.3
Diluted EPS Before Extra, 3 Yr. CAGR %	103.71	145.68	-17.11	-27.66	9.19
Accounts Receivable, 3 Yr. CAGR %	13.24	8.22	6.53	1.83	6.16
Inventory, 3 Yr. CAGR %	62.63	66.46	62.87	53.18	34.21
Net Property, Plant and Equip., 3 Yr. CAGR %	17.01	13.44	22.91	17.68	19.77
Total Assets, 3 Yr. CAGR %	19.08	19.31	22.15	10.57	13.41
Tangible Book Value, 3 Yr. CAGR %	24.21	29.97	18.41	1.76	1.27
Common Equity, 3 Yr. CAGR %	16.3	21.69	16.5	6.82	8.38
Cash From Operations, 3 Yr. CAGR %	56.87	6.36	-17.46	-21.4	64.25
Capital Expenditures, 3 Yr. CAGR %	-1.56	40.09	47.26	20.32	-14.13
Levered Free Cash Flow, 3 Yr. CAGR %	107.45	58.17	-45.06	-32.07	47.9
Unlevered Free Cash Flow, 3 Yr. CAGR %	107.42	57.93	-45.64	-31.96	48.33
Dividend Per Share, 3 Yr. CAGR %	11.2	19.28	20.84	13.3	6.69
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.48	13.84	11.39	12.05	12.8
Gross Profit, 5 Yr. CAGR %	15.46	12.18	8.07	10.42	13.43
EBITDA, 5 Yr. CAGR %	21.12	14.26	-4.9	4.66	13.63
EBITA, 5 Yr. CAGR %	22.94	17.08	-5.96	5.08	16.14
EBIT, 5 Yr. CAGR %	23.1	17.08	-5.96	5.08	16.14
Earnings From Cont. Operations, 5 Yr. CAGR %	29.01	25.37	-1.98	27.44	24.17
Net Income, 5 Yr. CAGR %	24.82	41.59	-6.1	56.64	36.98
Normalized Net Income, 5 Yr. CAGR %	18.56	23.02	-7.15	6.9	20.93
Diluted EPS Before Extra, 5 Yr. CAGR %	23.63	41.58	-5.36	57.38	36.85
Accounts Receivable, 5 Yr. CAGR %	11.26	7.4	9.09	7.46	4.89
Inventory, 5 Yr. CAGR %	75.82	55.02	64.29	65.85	37.74
Net Property, Plant and Equip., 5 Yr. CAGR %	14.16	16.97	18.66	15.98	19.74
Total Assets, 5 Yr. CAGR %	19.54	18.42	15.99	18.1	16.4
Tangible Book Value, 5 Yr. CAGR %	12.56	17.26	15.2	14.36	14
Common Equity, 5 Yr. CAGR %	10.83	12.62	11.63	14.59	15.23
Cash From Operations, 5 Yr. CAGR %	31.15	-3.66	-6.01	28.97	16.52
Capital Expenditures, 5 Yr. CAGR %	6.57	43.76	26.61	1.64	21.22
Levered Free Cash Flow, 5 Yr. CAGR %	45.19	29.02	-24.9	54.94	22.74
Unlevered Free Cash Flow, 5 Yr. CAGR %	45.19	28.89	-25.38	55.03	22.88
Dividend Per Share, 5 Yr. CAGR %	11.97	11.84	13.4	14.16	14.87